drugset / Trial / NCT01608295

Vilazodone for Treatment of Geriatric Depression

NCT01608295

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to examine the effects of vilazodone for the treatment of depression in older adults.

Timeline

Start
2012-07
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule 30 mg
Subject Vilazodone Small molecule 40 mg